Immuneering
IMRX
IMRX
34 hedge funds and large institutions have $56.9M invested in Immuneering in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
67% less capital invested
Capital invested by funds: $172M → $56.9M (-$116M)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$218K | |
| 2 | +$163K | |
| 3 | +$158K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$121K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$93.1K |
Top Sellers
| 1 | -$2.87M | |
| 2 | -$962K | |
| 3 | -$367K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$339K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$213K |